Medtronic's BrainSense™ Deep Brain Stimulation Earns Spot on TIME Best Innovations of 2025
Medtronic plc, a pioneer in healthcare technology, has made headlines with its innovative product, the BrainSense™ Adaptive Deep Brain Stimulation (aDBS), which has earned a coveted spot on TIME's list of Best Inventions of 2025. This cutting-edge technology represents a significant leap forward in treating Parkinson's disease, affecting millions worldwide.
With over 10 million individuals diagnosed with Parkinson's globally, the need for effective treatments has never been more pressing. While no cure exists, Medtronic’s deep brain stimulation (DBS) has been changing lives for over three decades. Its latest advancement incorporates an exclusive feature called BrainSense™, which personalizes therapy in real-time by monitoring brain activity, thus eliminating the need for patients to adjust their stimulation manually. This marks a significant improvement in the lives of those living with this degenerative condition.
The recognition by TIME is not merely a pat on the back; it emphasizes the profound impact of medical innovations on people's lives. The prestigious list showcases remarkable advancements across various fields, from artificial intelligence to healthcare. Medtronic's entry reflects its commitment to change lives through technology that matters.
Over the last twenty years, Medtronic has meticulously developed a sensing-enabled DBS system that captures and classifies complex brain signals. The integration of therapeutic brain-computer interface (BCI) technology into this DBS system positions Medtronic as a leader in the field. As TIME editors state, the BrainSense™ aDBS signifies a new era of neuromodulation.
Moreover, the BrainSense™ technology has received the necessary regulatory approvals, including both CE Mark and U.S. FDA sanctions, which paved the way for its launch. Currently, more than 1,000 patients worldwide have begun benefitting from this adaptive therapy, and results from the pivotal ADAPT-PD study published in JAMA Neurology highlight its clinical effectiveness and long-term safety.
Paolo Di Vincenzo, the president of Medtronic's Neuromodulation business, expresses pride in the recognition, underscoring the technology's purpose: to adapt to patients' changing needs while offering clinicians invaluable insights. This represents a step forward in setting higher standards for DBS therapy.
Since 1987, Medtronic's commitment to bettering the lives of patients has been unwavering. The company has helped over 200,000 people with movement disorders in more than 70 countries. The announcement of BrainSense™ Adaptive DBS as a TIME Best Invention aligns perfectly with Medtronic's mission to alleviate pain and restore health through technological advancements.
As a global leader, Medtronic continues to innovate relentlessly, emphasizing the importance of delivering therapies that address real-world health challenges. With a diverse team of over 95,000 employees working passionately across different nations, Medtronic is determined to transform healthcare, with innovations that impact lives daily. Expect more from this trailblazer in medical technologies, as it works towards a future where health improvements are accessible to all individuals in need.
For more details on Medtronic and its groundbreaking innovations, visit www.Medtronic.com, and stay updated by following them on LinkedIn.
With over 10 million individuals diagnosed with Parkinson's globally, the need for effective treatments has never been more pressing. While no cure exists, Medtronic’s deep brain stimulation (DBS) has been changing lives for over three decades. Its latest advancement incorporates an exclusive feature called BrainSense™, which personalizes therapy in real-time by monitoring brain activity, thus eliminating the need for patients to adjust their stimulation manually. This marks a significant improvement in the lives of those living with this degenerative condition.
The recognition by TIME is not merely a pat on the back; it emphasizes the profound impact of medical innovations on people's lives. The prestigious list showcases remarkable advancements across various fields, from artificial intelligence to healthcare. Medtronic's entry reflects its commitment to change lives through technology that matters.
Over the last twenty years, Medtronic has meticulously developed a sensing-enabled DBS system that captures and classifies complex brain signals. The integration of therapeutic brain-computer interface (BCI) technology into this DBS system positions Medtronic as a leader in the field. As TIME editors state, the BrainSense™ aDBS signifies a new era of neuromodulation.
Moreover, the BrainSense™ technology has received the necessary regulatory approvals, including both CE Mark and U.S. FDA sanctions, which paved the way for its launch. Currently, more than 1,000 patients worldwide have begun benefitting from this adaptive therapy, and results from the pivotal ADAPT-PD study published in JAMA Neurology highlight its clinical effectiveness and long-term safety.
Paolo Di Vincenzo, the president of Medtronic's Neuromodulation business, expresses pride in the recognition, underscoring the technology's purpose: to adapt to patients' changing needs while offering clinicians invaluable insights. This represents a step forward in setting higher standards for DBS therapy.
Since 1987, Medtronic's commitment to bettering the lives of patients has been unwavering. The company has helped over 200,000 people with movement disorders in more than 70 countries. The announcement of BrainSense™ Adaptive DBS as a TIME Best Invention aligns perfectly with Medtronic's mission to alleviate pain and restore health through technological advancements.
As a global leader, Medtronic continues to innovate relentlessly, emphasizing the importance of delivering therapies that address real-world health challenges. With a diverse team of over 95,000 employees working passionately across different nations, Medtronic is determined to transform healthcare, with innovations that impact lives daily. Expect more from this trailblazer in medical technologies, as it works towards a future where health improvements are accessible to all individuals in need.
For more details on Medtronic and its groundbreaking innovations, visit www.Medtronic.com, and stay updated by following them on LinkedIn.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.